Axelar Announces Final Data from Phase II Study with AXL1717 in Lung Cancer

News   Dec 27, 2013

 
Axelar Announces Final Data from Phase II Study with AXL1717 in Lung Cancer
 
 
 
FURTHER INFORMATION
 

This content appears on:

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks, Log In or Join Today

Login Join
 
 

Comments | 0 ADD COMMENT